|
|
|
Volumn 70, Issue SUPPL. 23, 1994, Pages
|
|
Treatment of langerhans cell histiocytosis - evolution and current approaches
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTIBIOTIC AGENT;
ANTIINFLAMMATORY AGENT;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
CYTARABINE;
CYTOSTATIC AGENT;
CYTOTOXIC AGENT;
DOXORUBICIN;
ETOPOSIDE;
MERCAPTOPURINE;
METHOTREXATE;
METHYLPREDNISOLONE;
PREDNISOLONE;
PREDNISONE;
STEROID;
THYMOPENTIN;
THYMOSTIMULIN;
THYMUS HORMONE;
VINBLASTINE;
VINCRISTINE;
BIOLOGICAL FACTOR;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DATA ANALYSIS;
DIABETES INSIPIDUS;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
FOLLOW UP;
HISTIOCYTOSIS;
HISTOPATHOLOGY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LANGERHANS CELL;
LEUKEMIA;
LYMPHADENOPATHY;
META ANALYSIS;
MORTALITY;
ORAL DRUG ADMINISTRATION;
PATHOGENESIS;
PRIORITY JOURNAL;
PUVA;
RECURRENT DISEASE;
REMISSION;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SKIN DISEASE;
SUBCUTANEOUS DRUG ADMINISTRATION;
SURVIVAL;
SYMPTOM;
SYSTEMIC DISEASE;
TOPICAL DRUG ADMINISTRATION;
CHILD;
CLASSIFICATION;
CONTROLLED CLINICAL TRIAL;
DRUG ADMINISTRATION;
HISTIOCYTOSIS X;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
BIOLOGICAL FACTORS;
CHILD;
CLINICAL TRIALS;
DRUG ADMINISTRATION SCHEDULE;
ETOPOSIDE;
HISTIOCYTOSIS, LANGERHANS-CELL;
HUMANS;
METHYLPREDNISOLONE;
RANDOMIZED CONTROLLED TRIALS;
REMISSION, SPONTANEOUS;
VINBLASTINE;
|
|
EID: 0027993777
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (140)
|
|
References (0)
|
